» Articles » PMID: 28250457

Genome-wide Analyses Identify Common Variants Associated with Macular Telangiectasia Type 2

Overview
Journal Nat Genet
Specialty Genetics
Date 2017 Mar 3
PMID 28250457
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic juxtafoveal retinal telangiectasis type 2 (macular telangiectasia type 2; MacTel) is a rare neurovascular degenerative retinal disease. To identify genetic susceptibility loci for MacTel, we performed a genome-wide association study (GWAS) with 476 cases and 1,733 controls of European ancestry. Genome-wide significant associations (P < 5 × 10) were identified at three independent loci (rs73171800 at 5q14.3, P = 7.74 × 10; rs715 at 2q34, P = 9.97 × 10; rs477992 at 1p12, P = 2.60 × 10) and then replicated (P < 0.01) in an independent cohort of 172 cases and 1,134 controls. The 5q14.3 locus is known to associate with variation in retinal vascular diameter, and the 2q34 and 1p12 loci have been implicated in the glycine/serine metabolic pathway. We subsequently found significant differences in blood serum levels of glycine (P = 4.04 × 10) and serine (P = 2.48 × 10) between MacTel cases and controls.

Citing Articles

Genetic Background of Macular Telangiectasia Type 2.

Kuncic A, Urbancic M, Dobovsek Divjak D, Hudler P, Debeljak N Int J Mol Sci. 2025; 26(2).

PMID: 39859398 PMC: 11765629. DOI: 10.3390/ijms26020684.


Characterization of the Retinal Phenotype Using Multimodal Imaging in Novel Compound Heterozygote Variants of CYP2U1.

Sallo F, Dysli C, Holzer F, Ranza E, Guipponi M, Antonarakis S Ophthalmol Sci. 2024; 5(1):100618.

PMID: 39605873 PMC: 11599445. DOI: 10.1016/j.xops.2024.100618.


Macular telangiectasia type 2 in a patient with Down syndrome: A possible association.

Halouani S, Miere A, Le H, Herda N, Cirneanu A, Souied E Am J Ophthalmol Case Rep. 2024; 36:102173.

PMID: 39319206 PMC: 11421271. DOI: 10.1016/j.ajoc.2024.102173.


Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2.

Amram A, Whitmore S, Wang C, Clavell C, Lyons L, Rusakevich A Br J Ophthalmol. 2024; 109(3):401-407.

PMID: 39288977 PMC: 11866295. DOI: 10.1136/bjo-2023-325115.


High-throughput ultrastructural analysis of macular telangiectasia type 2.

Zucker C, Bernstein P, Schalek R, Lichtman J, Dowling J Front Ophthalmol (Lausanne). 2024; 4:1428777.

PMID: 39140090 PMC: 11319912. DOI: 10.3389/fopht.2024.1428777.


References
1.
Clemons T, Gillies M, Chew E, Bird A, Peto T, Wang J . Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3. Ophthalmic Epidemiol. 2013; 20(2):109-13. DOI: 10.3109/09286586.2013.766757. View

2.
Borenstein M, Hedges L, Higgins J, Rothstein H . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2015; 1(2):97-111. DOI: 10.1002/jrsm.12. View

3.
Sim X, Jensen R, Ikram M, Cotch M, Li X, Macgregor S . Genetic loci for retinal arteriolar microcirculation. PLoS One. 2013; 8(6):e65804. PMC: 3680438. DOI: 10.1371/journal.pone.0065804. View

4.
Willer C, Schmidt E, Sengupta S, Peloso G, Gustafsson S, Kanoni S . Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013; 45(11):1274-1283. PMC: 3838666. DOI: 10.1038/ng.2797. View

5.
Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E . Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum Mutat. 2010; 31(6):722-33. DOI: 10.1002/humu.21253. View